Clinical Trial Update: First-line Metastatic Pancreatic Cancer : FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating maintenance strategies in first-line metastatic pancreatic cancer, comparing continued FOLFIRINOX +/- LV5FU2 versus Firgem; results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• FOLFIRINOX
• Firgem
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-07-10